News
To lessen bruising, do not rub the injection site after each dose. Learn how to store and discard medical supplies safely. Patients who are getting immune globulin for the first time, those who ...
7d
Clinical Trials Arena on MSNDesentum to advance pollen allergy vaccine after positive Phase I trialThe company’s Phase I trial saw nearly all patients in the trial reaching their targeted maximum dose of DM-101PX.
HyQvia is the only up to once monthly (every 2, 3 or 4 weeks) immunoglobulin subcutaneous infusion to treat CIDP in Canada TORONTO, March 27, 2025 /CNW/ - Takeda Canada Inc. (Takeda) is pleased to ...
3 For subcutaneous induction, guselkumab should be dosed at 400 mg at weeks 0, 4, and 8 as 2 consecutive 200-mg injections from a single induction pack. 1 Guselkumab also comes in a 200-mg ...
1mon
Medpage Today on MSNFirst Omalizumab Biosimilar ApprovedThe anti-immunoglobulin E (IgE ... at least 3% of adults reported headache, injection site reactions, arthralgia, upper ...
Omlyclo, formerly known as CT-P39, is an anti-immunoglobulin E (IgE ... 0.5mL and a 150mg/mL single-dose prefilled syringe for subcutaneous injection. The product should be initially administered ...
PRINCETON, NJ, USA & TOKYO, Japan I March 31, 2025 I Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results